Medication used to treat fungal infections
Itraconazole Trade names Sporanox, Sporaz, Orungal, others Other names ITZ AHFS /Drugs.com Monograph MedlinePlus a692049 License data
Pregnancy category Routes of administration By mouth , solution ), vaginal suppository , intravenous ATC code Legal status
Bioavailability ~55%, maximal if taken with full meal Protein binding 99.8% Metabolism Extensive in liver (CYP3A4 ) Metabolites Hydroxy-itraconazole, keto-itraconazole,N -desalkyl-itraconazole[ 4] Elimination half-life 21 hours Excretion Kidney (35%), faeces (54%)[ 5]
(±)-1-[(RS )-sec -butyl]-4-[p -[4-[p -[[(2R ,4S )-rel -2-(2,4-dichlorophenyl)-2-(1H -1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-Δ2 -1,2,4-triazolin-5-one
CAS Number PubChem CID DrugBank ChemSpider UNII KEGG ChEBI ChEMBL CompTox Dashboard (EPA ) ECHA InfoCard 100.123.596 Formula C 35 H 38 Cl 2 N 8 O 4 Molar mass 705.64 g·mol−1 3D model (JSmol ) Chirality Racemic mixture Melting point 165[ 6] °C (329 °F) Solubility in water 7.8 ± 0.4 × 10−6 mol/L (pH 1.6)[ 6] mg/mL (20 °C)
O=C1N(/N=C\N1c2ccc(cc2)N7CCN(c6ccc(OC[C@@H]3O[C@](OC3)(c4ccc(Cl)cc4Cl)Cn5ncnc5)cc6)CC7)C(C)CC
InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/m0/s1
Y Key:VHVPQPYKVGDNFY-ZPGVKDDISA-N
Y
(verify)
Itraconazole , sometimes abbreviated ITZ , is an antifungal medication used to treat a number of fungal infections .[ 7] This includes aspergillosis , blastomycosis , coccidioidomycosis , histoplasmosis , and paracoccidioidomycosis .[ 7] It may be given by mouth or intravenously .[ 7]
Common side effects include nausea, diarrhea, abdominal pain, rash, and headache.[ 7] Severe side effects may include liver problems , heart failure , Stevens–Johnson syndrome and allergic reactions including anaphylaxis .[ 7] It is unclear if use during pregnancy or breastfeeding is safe.[ 1] It is in the triazole family of medications.[ 7] It stops fungal growth by affecting the cell membrane or affecting their metabolism .[ 7]
Itraconazole was patented in 1978 and approved for medical use in the United States in 1992.[ 7] [ 8] It is on the World Health Organization's List of Essential Medicines .[ 9]
Recent research works suggest itraconazole (ITZ) could also be used in the treatment of cancer by inhibiting the hedgehog pathway [ 10] in a similar way to sonidegib .
^ a b "Itraconazole Use During Pregnancy" . Drugs.com . 20 March 2019. Retrieved 15 May 2020 .
^ "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)" . nctr-crs.fda.gov . FDA . Retrieved 22 October 2023 .
^ "Sporanox 10 mg/mL Oral Solution - Summary of Product Characteristics (SmPC)" . (emc) . 1 February 2018. Retrieved 15 May 2020 .
^ Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE (October 2004). "Role of itraconazole metabolites in CYP3A4 inhibition". Drug Metabolism and Disposition . 32 (10): 1121–1131. doi :10.1124/dmd.104.000315 . PMID 15242978 . S2CID 6941636 .
^ "Sporanox (itraconazole) Capsules. Full Prescribing Information" (PDF) . Janssen Pharmaceuticals, Inc. Archived from the original (PDF) on 17 May 2018. Retrieved 28 August 2016 .
^ a b Vasilev NA, Surov AO, Voronin AP, Drozd KV, Perlovich GL (April 2021). "Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility". International Journal of Pharmaceutics . 599 : 120441. doi :10.1016/j.ijpharm.2021.120441 . PMID 33675927 . S2CID 232135660 .
^ a b c d e f g h "Itraconazole" . The American Society of Health-System Pharmacists. Retrieved 8 December 2017 .
^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery . John Wiley & Sons. p. 503. ISBN 9783527607495 .
^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019 . Geneva: World Health Organization. hdl :10665/325771 . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
^ Li K, Fang D, Xiong Z, Luo R (2019). "Inhibition of the hedgehog pathway for the treatment of cancer using Itraconazole" . OncoTargets and Therapy . 12 : 6875–6886. doi :10.2147/OTT.S223119 . PMC 6711563 . PMID 31692536 .